Michael James
Michael is co-founder and Chief Architect of Advanced Technologies at Cerebras, the company that created the world’s largest and most powerful computer processor. Michael leads the effort to reimagine the algorithmic building blocks for the next generation of AI technologies. Prior to Cerebras, Michael was a Fellow at AMD, where he pioneered a technique of adaptive and self-healing circuits based on cellular automata that was applied toward distributed fault tolerant machines. Michael focuses his career on exploration at the intersection of natural phenomena, mathematics, and engineered machines.
Shimon Ben David
As WekaIO’s CTO, Mr Shimon Ben-David actively engages with customers and partners to track emerging trends and to bring actionable feedback to Engineering and Product Management, with a focus on Financials and Life science markets as well as AI/ML and GPU workloads. In his more than 6 years at WekaIO, he grew with leadership roles in both Support and Sales Engineering organizations. Prior to joining WekaIO he led the Support Services for Primary Data, XtremIO, and IBM XIV. Shimon met the leadership team of WekaIO when he managed IT at XIV, acquired by IBM in 2007.
Sorin Cheran
Sorin Cheran is an HPE Fellow and currently serves as vice president of HPE’s AI Strategy and Solutions Group which is responsible for the company’s global AI strategy. Since 2007, Sorin has held positions including AI and Chief Architect in Hewlett Packard Labs and as a key member in the Hybrid IT Presales team in the High-Performance Computing (HPC) and AI Competency Center in Grenoble, France. Sorin’s drive, creativity, energetic leadership and spirit of collaboration consistently delivers outstanding business outcomes for HPE and its customers. He has nurtured and evangelized Artificial Intelligence within HPE, as well as externally with customers and partners.
is an HPE Fellow and currently serves as vice president of HPE’s AI Strategy and Solutions Group which is responsible for the company’s global AI strategy. Since 2007, Sorin has held positions including AI and Chief Architect in Hewlett Packard Labs and as a key member in the Hybrid IT Presales team in the High-Performance Computing (HPC) and AI Competency Center in Grenoble, France. Sorin’s drive, creativity, energetic leadership and spirit of collaboration consistently delivers outstanding business outcomes for HPE and its customers. He has nurtured and evangelized Artificial Intelligence within HPE, as well as externally with customers and partners.
Oliver Garfield
Simon Hann
Simon is involved in a wide range of policy and research based projects and with a background in design, he is interested in how the products we use everyday can be improved to better the environment.
Simon joined Eunomia in 2013 as the in-house Life Cycle Assessment(LCA) specialist after seven years working for an internationally recognised UK manufacturer, Kohler Mira Ltd. Whilst working as an engineer he developed an extensive knowledge base of materials and processes whilst studying for an MSc in Sustainable Product Design. His thesis, which looked at how LCA can be integrated into the design process, was awarded a distinction and the tools and models developed as an output continue to be used by Kohler.
Emilie Gauthy
James O'Brien
Sridevi Narayan-Sarathy
Sri Narayan-Sarathy is Senior Principal Scientist with PepsiCo and member of the elite PepsiCo R&D Fellows program. Sri received her M.Sc. in Chemistry and M.Tech. in Polymer Science & Technology from Indian Institutes of Chennai and Delhi respectively. She got her Ph.D. in Polymer Science & Engineering from the University of Massachusetts at Amherst. Prior to joining PepsiCo in 2010, Sri was Technology Manager/Principal Scientist at Ashland Performance Materials. Sri’s research interests are in the areas of Materials Science and Chemistry. At PepsiCo, she is leveraging her extensive experience with different polymer chemistries to identify and develop bio-based materials for sustainable flexible packaging with good end of life. She has several patents and publications to her credit. Sri also has an adjunct faculty appointment in the Department of Grain Sciences at Kansas State University.
Daniel Fitzgerald
Dan Fitzgerald is Stanley Black & Decker’s Product Sustainability Lead and is responsible for identifying, defining, and facilitating all strategies and action plans associated with improving the sustainable performance of products across the corporation. He leads the “Innovate with Purpose” pillar of the Corporate Social Responsibility strategy which includes goals to develop products that address unmet societal needs and to improve the impacts of products across their lifecycle. He joined Stanley Black & Decker in 2006 and spent his first ten years at the company in a product stewardship role providing safety and environmental compliance support for the Power Tools Business. Dan holds a B.S., M.S. and Ph.D. in Mechanical Engineering from the University of Maryland – College Park.
Krishnan Viswanadhan
Dr. Krishnan Viswanadhan is a biopharmaceutical executive with over 20 years of broad cross-functional experience in advancing new medicines for patients with serious and life-threatening diseases. Krishnan is currently President and Chief Operating Officer at Be Biopharma, a leader in engineered B cells as a new category of medicines for patients with serious diseases.
Prior to Be Bio, Krishnan was Senior Vice President, Global Cell Therapy Franchise Lead at Bristol Myers Squibb where he was responsible for overseeing the integrated cell therapy franchise strategy across the enterprise including building core capabilities and key investments to support long term growth. He oversaw the teams responsible for the development, approval, and life cycle management of Breyanzi, a CD19 CAR T and Abecma, the first BCMA CAR T therapy.
Prior to BMS, Krishnan was Vice President, Business Development and Global Alliances at Celgene Corporation responsible for managing the portfolio of partnerships and equity investments. Prior to Celgene, Krishnan had roles in large and small companies in regulatory strategy.
Dr. Viswanadhan is a registered Pharmacist and received his Doctor of Pharmacy degree from Rutgers University and holds a Master of Business Administration degree from Cornell University.
Krishnan currently serves the board as a non-executive director of JW Therapeutics, a leading cell therapy company in China.